Associated Papers
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomas.
Reis H et al.
Lung Cancer (amsterdam, Netherlands), 2015
Select a paper to view details